This focused series on “Pulmonary Metastases” is edited by Prof. Khosro Hekmat from Department of Cardiothoracic Surgery, University of Cologne, Cologne, Germany.
In this series, we offer a comprehensive synopsis of the management of different primary tumors with lung metastases. The treatment strategies for lung metastases has become more complex. The lack of consensus guidelines forces us to discuss the indication for lung metastasis surgery as part of a multidisciplinary tumor board, which is made up of pneumologists, medical oncologists, radiologists, pathologists and surgeons. With the development of more effective systemic therapy for pulmonary metastatic disease, it is probable that more patients will be considered candidates for a multimodal management of pulmonary metastases from different primary tumors.
Modern management of pulmonary metastases (Preface)
The epidemiology and biology of pulmonary metastases
Preoperative evaluation and indications for pulmonary metastasectomy
Pulmonary metastasectomy: limits to credibility
Lymphadenectomy in pulmonary metastasectomy
Pulmonary metastasectomy in the era of targeted therapy and immunotherapy
Pulmonary metastasectomy in colorectal carcinoma
Pulmonary metastasectomy in renal cell carcinoma: a mainstay of multidisciplinary treatment
The role of pulmonary metastasectomy for pulmonary metastasis from head and neck cancer
Pulmonary metastasectomy in soft tissue sarcomas: a systematic review
Pulmonary metastasectomy in germ cell tumors and prostate cancer
Results of redo pulmonary metastasectomy
Multimodal and palliative treatment of patients with pulmonary metastases
Does a thoracoscopic approach provide better outcomes for pulmonary metastases?
Disclosure:
The series “Pulmonary Metastases” was commissioned by the editorial office, Journal of Thoracic Disease without any funding or sponsorship. Khosro Hekmat is serving as the unpaid Guest Editor for the focused issue.